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Growth of  marine organisms, fouling, on man-made constructions submerged 
in the water is regarded as a major problem. For vessels, fouling increases drag and 
thereby fuel consumption, wherefore antifouling paints are used. Traditionally, 
they contain toxic compounds, and several of  these have unwanted effects in 
the environment. Today the search for environmentally acceptable and efficient 
alternatives is intense. 
Medetomidine, originally used as a veterinary sedative, inhibits barnacle 
settling at nanomolar concentrations. It is presently under evaluation for use as 
an antifouling agent. The studies within this thesis were performed to investigate 
medetomidine responses in fish. The focus was to identify early effects, occurring 
from low concentrations. Studies have been performed in the species rainbow trout, 
Atlantic cod, turbot, Atlantic salmon and three spined stickleback. Exposure time 
vary from 1 up to 54 days, and a set of  parameters have been investigated including 
biochemical biomarkers, growth and related parameters, behaviour and large scale 
gene expression.
Paleness is the most obvious effect of  medetomidine in fish and appears from 
0.5 to 50 nM, depending on species. Colour was observed and quantified, and the 
function of  melanophores (pigment cells) after long term exposure to medetomidine 
was investigated. It is suggested that melanophores are functional after treatment, and 
thus the colour change may be reversible. Although not lethal per-see, paleness may 
have consequences for fish predator-prey interactions (camouflage), social signalling 
and UV protection.
Medetomidine also showed to affect the activity of  the hepatic enzyme 
Cytochrome P4501A (CYP1A), measured as EROD activity. A minor increase 
in activity was observed in vivo in several of  the investigated species. In vitro, 
medetomidine showed instead to be a potent inhibitor of  EROD activity with median 
inhibition values (IC50) in the nanomolar range. An inhibited CYP1A activity may 
interfere with fish detoxification of  toxicants abundant in the aquatic environment.    
No significant effects were found on growth rate, but the results indicate lowered 
blood glucose levels and decreased liver size after medetomidine treatment and thus 
a shift in carbohydrate metabolism. The large scale gene expression study revealed 
no significant differences among treatments. We found no effects on glutathione 
or glutathione dependent enzymes in any of  the studies. In the behavioural studies, 
fish were less active and had less appetite in medetomidine treatments compared 
to control. Medetomidine had no effects on investigated antioxidant enzymes and 
showed no cytotoxicity.
Among the responses studied within this thesis, paleness and inhibition of  
EROD activity are perhaps the most important. These effects appear early and are 
clear and consistent among several species. 
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